Japer Therapeutics Warrants
JSPRW
6 hedge funds and large institutions have $187K invested in Japer Therapeutics Warrants in 2026 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
14% less funds holding
Funds holding: 7 → 6 (-1)
50% less capital invested
Capital invested by funds: $372K → $187K (-$185K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$9 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$618 |
| 2 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$2 |
JSPRW Hedge Fund Activity: Q2 2026 in Review
6 of the 8,320 institutional investors tracked by Wall St. Rank reported a position in Japer Therapeutics Warrants (JSPRW) for Q2 2026, worth a combined $187K — down 50% from $372K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of JSPRW and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Wolverine Asset Management, adding an estimated $9. The largest seller was Susquehanna International Group, exiting entirely with an estimated $618 sold.
- 6 institutional investors held Japer Therapeutics Warrants (JSPRW) as of Q2 2026, down from 7 in Q1 2026.
- Funds reported $187K of Japer Therapeutics Warrants stock for Q2 2026, down 50% quarter-over-quarter.
- 0 funds opened new Japer Therapeutics Warrants positions in Q2 2026 and 1 closed out, a net change of -1 holder.
- The largest Japer Therapeutics Warrants buyer in Q2 2026 was Wolverine Asset Management, an estimated $9 added.
- The largest Japer Therapeutics Warrants seller in Q2 2026 was Susquehanna International Group, an estimated $618 sold.
Based on aggregated 13F filings for Q2 2026.